Treace Medical Concepts Inc (TMCI) — Capital Reinvestment Ratio

Latest as of March 2026: 0.42x

Treace Medical Concepts Inc (TMCI) has a Capital Reinvestment Ratio of 0.42x as of March 2026, meaning it reinvests 0% of its operating cash flow ($7.24 Million) in capital expenditures ($3.06 Million). See TMCI equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.42x

Capex / Operating Cash Flow

Operating Cash Flow

$7.24 Million

USD

Capital Expenditures

$3.06 Million

USD

Data as of

Mar 2026

Most recent filing

Annual Capital Reinvestment Ratio for Treace Medical Concepts Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Treace Medical Concepts Inc from None to None. For live market cap and broader valuation context, see Treace Medical Concepts Inc (TMCI) market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow